NCT01583608View on ClinicalTrials.gov

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2016

Conditions
Cardiovascular DiseasesCoronary Artery DiseaseMyocardial IschemiaCoronary DiseaseCoronary RestenosisHeart DiseasesCoronary StenosisArteriosclerosisArterial Occlusive DiseasesVascular Diseases
Trial Locations (6)

16321

Herzzentrum Brandenburg in Bernau, Bernau

22527

Medical Care Center Prof. Mathey, Prof. Schofer GmbH, Hamburg

24105

Universitätsklinikum Schleswig-Holstein, Kiel

45138

Elisabeth-Krankenhaus Essen GmbH, Essen

89081

Universitätsklinikum Ulm, Ulm

96450

Klinikum Coburg GmbH, Coburg

Sponsors

Collaborators (1)

Abbott Medical Devices
All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

lead

Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.

OTHER